advertisement
Wormald R 97
Showing records 1 to 25 | Display only abstracts from Wormald R in IGR 20-3105992 Differences in the Surgical Outcomes of Glaucoma Surgery in Patients of African Caribbean Descent
Nagar AM; Maghsoudlou P; Wormald R; Barton K; Hysi P; Lim KS
Current Eye Research 2022; 47: 1567-1577 (IGR: 23-3)
104879 Laser trabeculoplasty for open-angle glaucoma and ocular hypertension
Rolim-de-Moura CR; Paranhos A; Loutfi M; Burton D; Wormald R; Evans JR
Cochrane Database of Systematic Reviews 2022; 8: CD003919 (IGR: 23-2)
96041 Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma: An Overview of Cochrane Systematic Reviews and Network Meta-analysis
Bicket AK; Le JT; Azuara-Blanco A; Gazzard G; Wormald R; Bunce C; Hu K; Jayaram H; King A; Otárola F; Nikita E; Shah A; Stead R; Tóth M; Li T
JAMA ophthalmology 2021; 139: 983-989 (IGR: 22-3)
84667 Systematic reviews and randomised controlled trials on open angle glaucoma
Wormald R; Virgili G; Azuara-Blanco A
Eye 2020; 34: 161-167 (IGR: 21-1)
82879 Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial
Garg A; Vickerstaff V; Nathwani N; Garway-Heath D; Konstantakopoulou E; Ambler G; Bunce C; Wormald R; Barton K; Gazzard G;
Ophthalmology 2020; 127: 467-476 (IGR: 20-4)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Gazzard G
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Garg A
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gazzard G; Konstantakopoulou E
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Vickerstaff V
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Konstantakopoulou E
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garway-Heath D
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Garway-Heath D
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Nathwani N; Garway-Heath D
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garg A
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Garg A
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Konstantakopoulou E
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Vickerstaff V
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Vickerstaff V
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Hunter R
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Hunter R
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Ambler G
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Ambler G
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
80933 Primary Selective Laser Trabeculoplasty for Open-Angle Glaucoma and Ocular Hypertension: Clinical Outcomes, Predictors of Success, and Safety from the Laser in Glaucoma and Ocular Hypertension Trial
Bunce C
Ophthalmology 2019; 126: 1238-1248 (IGR: 20-3)
81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Ambler G
Health Technol Assess 2019; 23: 1-102 (IGR: 20-3)
80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Bunce C
Lancet 2019; 393: 1505-1516 (IGR: 20-3)
